ACTH action on messenger RNA stability mechanisms

Frontiers in Endocrinology

Volumn 8, Issue JAN, 2017, Pages

  Desroches Castan, Agnès ^a,b,c   Feige, Jean Jacques ^a,b,c   Cherradi, Nadia ^a,b,c  

^a INSERM   (France)

^b DIF   (France)

^c UNIV GRENOBLE ALPES   (France)

Author keywords

ACTH; AU rich elements; HuR; mRNA stability; RNA binding proteins; TIS11b BRF1; Tristetraprolin

Indexed keywords

BUTYRATE RESPONSE FACTOR 1; CORTICOTROPIN; CYCLIC AMP; MESSENGER RNA; MUTANT PROTEIN; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE; STEROIDOGENIC ACUTE REGULATORY PROTEIN; TRISTETRAPROLIN;

ADRENAL CORTEX CELL; ANGIOGENESIS; ARTICLE; AU RICH ELEMENT; CARCINOGENESIS; CELL FUNCTION; COS-1 CELL LINE; EXOSOME; GENETIC TRANSCRIPTION; HUMAN; IMMUNOBLOTTING; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA STABILITY; THERMODYNAMICS; TRANSCRIPTION REGULATION;

EID: 85011844347     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2017.0003     Document Type: Article

References (34)

1. Stocco DM. StAR protein and the regulation of steroid hormone biosynthesis. Annu Rev Physiol (2001) 63:193-213. doi: 10.1146/annurev.physiol.63.1.193.
2. Lefrancois-Martinez AM, Blondet-Trichard A, Binart N, Val P, Chambon C, Sahut-Barnola I, et al. Transcriptional control of adrenal steroidogenesis: novel connection between Janus kinase (JAK) 2 protein and protein kinase A (PKA) through stabilization of cAMP response element-binding protein (CREB) transcription factor. J Biol Chem (2011) 286:32976-85. doi:10.1074/jbc.M111.218016.
3. Sewer MB, Waterman MR. Insights into the transcriptional regulation of steroidogenic enzymes and StAR. Rev Endocr Metab Disord (2001) 2:269-74. doi:10.1023/A:1011516532335.
4. Feige JJ, Keramidas M, Chambaz EM. Hormonally regulated components of the adrenocortical cell environment and the control of adrenal cortex homeostasis. Horm Metab Res (1998) 30:421-5. doi:10.1055/s-2007-978908.
5. Gaillard I, Keramidas M, Liakos P, Vilgrain I, Feige JJ, Vittet D. ACTH-regulated expression of vascular endothelial growth factor in the adult bovine adrenal cortex: a possible role in the maintenance of the microvasculature. J Cell Physiol (2000) 185:226-34. doi:10.1002/1097-4652(200011)185:2<226::AID-JCP7>3.0.CO;2-E.
6. Cherradi N, Lejczak C, Desroches-Castan A, Feige JJ. Antagonistic functions of tetradecanoyl phorbol acetate-inducible-sequence 11b and HuR in the hormonal regulation of vascular endothelial growth factor messenger ribonucleic acid stability by adrenocorticotropin. Mol Endocrinol (2006) 20:916-30. doi:10.1210/me.2005-0121.
7. Stoecklin G, Muhlemann O. RNA decay mechanisms: specificity through diversity. Biochim Biophys Acta (2013) 1829:487-90. doi:10.1016/j.bbagrm.2013.04.002.
8. Planel S, Rataj F, Feige JJ, Cherradi N. Posttranscriptional regulation of angiogenesis through AU-rich mRNA degradation: potential application in cancer therapy. In: Feige JJ, Pagès G, Soncin F, editors. Molecular Mechanisms of Angiogenesis from Ontogenesis to Oncogenesis. France: Springer-Verlag (2014). p. 353-72.
9. Hitti E, Khabar KS. Sequence variations affecting AU-rich element function and disease. Front Biosci (Landmark Ed) (2012) 17:1846-60. doi:10.2741/4023.
10. Bakheet T, Williams BR, Khabar KS. ARED 3.0: the large and diverse AU-rich transcriptome. Nucleic Acids Res (2006) 34:D111-4. doi:10.1093/nar/gkj052.
11. Simone LE, Keene JD. Mechanisms coordinating ELAV/Hu mRNA regulons. Curr Opin Genet Dev (2013) 23:35-43. doi:10.1016/j.gde.2012.12.006.
12. Matsumoto K, Wassarman KM, Wolffe AP. Nuclear history of a pre-mRNA determines the translational activity of cytoplasmic mRNA. EMBO J (1998) 17:2107-21. doi:10.1093/emboj/17.7.2107.
13. Fan XC, Steitz JA. HNS, a nuclear-cytoplasmic shuttling sequence in HuR. Proc Natl Acad Sci U S A (1998) 95:15293-8. doi:10.1073/pnas.95.26.15293.
14. Linker K, Pautz A, Fechir M, Hubrich T, Greeve J, Kleinert H. Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR. Nucleic Acids Res (2005) 33:4813-27. doi:10.1093/nar/gki797.
15. Taylor GA, Carballo E, Lee DM, Lai WS, Thompson MJ, Patel DD, et al. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity (1996) 4:445-54. doi:10.1016/S1074-7613(00)80411-2.
16. Stumpo DJ, Byrd NA, Phillips RS, Ghosh S, Maronpot RR, Castranio T, et al. Chorioallantoic fusion defects and embryonic lethality resulting from disruption of Zfp36L1, a gene encoding a CCCH tandem zinc finger protein of the Tristetraprolin family. Mol Cell Biol (2004) 24:6445-55. doi:10.1128/MCB.24.14.6445-6455.2004.
17. Bell SE, Sanchez MJ, Spasic-Boskovic O, Santalucia T, Gambardella L, Burton GJ, et al. The RNA binding protein Zfp36l1 is required for normal vascularisation and post-transcriptionally regulates VEGF expression. Dev Dyn (2006) 235:3144-55. doi:10.1002/dvdy.20949.
18. Stumpo DJ, Broxmeyer HE, Ward T, Cooper S, Hangoc G, Chung YJ, et al. Targeted disruption of Zfp36l2, encoding a CCCH tandem zinc finger RNA-binding protein, results in defective hematopoiesis. Blood (2009) 114:2401-10. doi:10.1182/blood-2009-04-214619.
19. Hudson BP, Martinez-Yamout MA, Dyson HJ, Wright PE. Recognition of the mRNA AU-rich element by the zinc finger domain of TIS11d. Nat Struct Mol Biol (2004) 11:257-64. doi:10.1038/nsmb738.
20. Lykke-Andersen J, Wagner E. Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1. Genes Dev (2005) 19:351-61. doi:10.1101/gad.1282305.
21. Chinn AM, Ciais D, Bailly S, Chambaz E, LaMarre J, Feige JJ. Identification of two novel ACTH-responsive genes encoding manganese-dependent superoxide dismutase (SOD2) and the zinc finger protein TIS11b [tetradecanoyl phorbol acetate (TPA)-inducible sequence 11b]. Mol Endocrinol (2002) 16:1417-27. doi:10.1210/mend.16.6.0844.
22. Duan H, Cherradi N, Feige JJ, Jefcoate C. cAMP-dependent posttranscriptional regulation of steroidogenic acute regulatory (STAR) protein by the zinc finger protein ZFP36L1/TIS11b. Mol Endocrinol (2009) 23:497-509. doi:10.1210/me.2008-0296.
23. Rataj F, Planel S, Desroches-Castan A, Le Douce J, Lamribet K, Denis J, et al. The cAMP pathway regulates mRNA decay through phosphorylation of the RNA-binding protein TIS11b/BRF1. Mol Biol Cell (2016) 27:3841-54. doi:10.1091/mbc.E16-06-0379.
24. Ciais D, Cherradi N, Bailly S, Grenier E, Berra E, Pouyssegur J, et al. Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b. Oncogene (2004) 23:8673-80. doi:10.1038/sj.onc.1207939.
25. Clark BJ, Combs R. Angiotensin II and cyclic adenosine 3',5'-monophosphate induce human steroidogenic acute regulatory protein transcription through a common steroidogenic factor-1 element. Endocrinology (1999) 140:4390-8. doi:10.1210/en.140.10.4390.
26. Hitti E, Iakovleva T, Brook M, Deppenmeier S, Gruber AD, Radzioch D, et al. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol Cell Biol (2006) 26:2399-407. doi:10.1128/MCB.26.6.2399-2407.2006.
27. Chrestensen CA, Schroeder MJ, Shabanowitz J, Hunt DF, Pelo JW, Worthington MT, et al. MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding. J Biol Chem (2004) 279:10176-84. doi:10.1074/jbc.M310486200.
28. Maitra S, Chou CF, Luber CA, Lee KY, Mann M, Chen CY. The AU-rich element mRNA decay-promoting activity of BRF1 is regulated by mitogen-activated protein kinase-activated protein kinase 2. RNA (2008) 14:950-9. doi:10.1261/rna.983708.
29. Schmidlin M, Lu M, Leuenberger SA, Stoecklin G, Mallaun M, Gross B, et al. The ARE-dependent mRNA-destabilizing activity of BRF1 is regulated by protein kinase B. EMBO J (2004) 23:4760-9. doi:10.1038/sj.emboj.7600477.
30. Benjamin D, Moroni C. mRNA stability and cancer: an emerging link? Expert Opin Biol Ther (2007) 7:1515-29. doi:10.1517/14712598.7.10.1515.
31. Brennan SE, Kuwano Y, Alkharouf N, Blackshear PJ, Gorospe M, Wilson GM. The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis. Cancer Res (2009) 69:5168-76. doi:10.1158/0008-5472.CAN-08-4238.
32. Griseri P, Bourcier C, Hieblot C, Essafi-Benkhadir K, Chamorey E, Touriol C, et al. A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. Hum Mol Genet (2011) 20:4556-68. doi:10.1093/hmg/ddr390.
33. Al-Souhibani N, Al-Ahmadi W, Hesketh JE, Blackshear PJ, Khabar KS. The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes. Oncogene (2010) 29:4205-15. doi:10.1038/onc.2010.168.
34. Murray RD, Merchant ML, Hardin E, Clark B, Khundmiri SJ, Lederer ED. Identification of an RNA-binding protein that is phosphorylated by PTH and potentially mediates PTH-induced destabilization of Npt2a mRNA. Am J Physiol Cell Physiol (2016) 310:C205-15. doi:10.1152/ajpcell.00192.2015.